Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1357-1375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Innovative Therapeutical Approaches for Hematological Malignancies Based on Molecular Targeted Therapies (Executive Editor: Giorgio Zauli) ]

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2022-2022

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Radiotherapy of Bone Malignancies

Current Drug Discovery Technologies, Vol. 7, Iss. 4, 2010-12 ,pp. : 233-246

Bentham Science Publishers

Access to resources Recommend Favorite

Vemurafenib: Targeted Inhibition of Mutated BRAF for Treatment of Advanced Melanoma and Its Potential in Other Malignancies

By Sharma Anant Shah Sachin R. Illum Henrik Dowell Jonathan

Drugs, Vol. 72, Iss. 17, 2012-12 ,pp. : 2207-2222

Adis International

Access to resources Recommend Favorite

Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies

Current Drug Targets, Vol. 16, Iss. 10, 2015-09 ,pp. : 1142-1159

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Developments in RNA Therapeutics

By Read Martin L Farrow Paul J Seymour Leonard W

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 299-303

Informa Healthcare

Access to resources Recommend Favorite